For instance, a retrospective analysis showed that colitis was less likely to recur in comparison to hepatitis, pancreatitis, pneumonitis and nephritis, and re-challenge with PD-1 blockade has been reported to be tolerated better than other agents (134). This evidence concerns the gene PDCD1 and pancreatitis.